[#item_full_content] The U.S. Department of the Treasury and the Internal Revenue Service (IRS) will issue guidance that addresses the federal tax consequences of increasing medical marijuana research.© Shutterstock Specifically, the guidance stems from the U.S. Department of Justice’s (DOJ) final order implementing President Donald Trump’s executive order on increasing medical marijuana and cannabidiol research. The executive 
Read More
